 Fox's Carmen Roberts. The drug company Pfizer says an early stage study is encouraging enough to continue development of its once-a-day weight loss pill. I'm Chris Foster, Fox News. Hey, New River Valley, this is Mark Tapp. And this is Keith Weltons. And we're the co-hosts of AM HodgePot. Tune in every Saturday when we get you caught up in what's going on in the New River Valley. We'll have special local guests. And we even have a beer segment.